News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
114,770 Results
Type
Article (1904)
Company Profile (4)
Press Release (112862)
Section
Business (41332)
Career Advice (94)
Deals (8172)
Drug Delivery (12)
Drug Development (19147)
Employer Resources (9)
FDA (2925)
Job Trends (3218)
News (70127)
Policy (5122)
Tag
Academia (82)
Alliances (6259)
Alzheimer's disease (241)
Approvals (2928)
Artificial intelligence (34)
Bankruptcy (70)
Best Places to Work (3179)
Breast cancer (82)
Cancer (565)
Cardiovascular disease (32)
Career advice (74)
Cell therapy (109)
Clinical research (16669)
Collaboration (165)
Compensation (90)
COVID-19 (305)
C-suite (42)
Data (695)
Diabetes (54)
Diagnostics (1602)
Earnings (29110)
Events (15888)
Executive appointments (145)
FDA (3174)
Funding (149)
Gene therapy (57)
GLP-1 (107)
Government (316)
Healthcare (3020)
Infectious disease (329)
IPO (4950)
Job creations (326)
Job search strategy (50)
Layoffs (49)
Legal (804)
Lung cancer (81)
Lymphoma (44)
Manufacturing (63)
Medical device (2457)
Medtech (2457)
Mergers & acquisitions (3357)
Metabolic disorders (147)
Neuroscience (335)
NextGen Class of 2024 (667)
Non-profit (104)
Northern California (799)
Obesity (97)
Opinion (27)
Parkinson's disease (33)
Patents (41)
People (6220)
Phase I (5025)
Phase II (7360)
Phase III (5833)
Pipeline (345)
Postmarket research (384)
Preclinical (1502)
Prostate cancer (27)
Radiopharmaceuticals (56)
Rare diseases (58)
Real estate (422)
Regulatory (4310)
Research institute (110)
Southern California (688)
Startups (198)
United States (5829)
Vaccines (75)
Weight loss (54)
Date
Today (2)
Last 7 days (374)
Last 30 days (1315)
Last 365 days (11583)
2024 (11356)
2023 (10712)
2022 (11535)
2021 (11775)
2020 (11106)
2019 (6823)
2018 (5100)
2017 (5948)
2016 (4693)
2015 (6013)
2014 (4144)
2013 (2602)
2012 (2911)
2011 (3196)
2010 (2952)
Location
Africa (48)
Arizona (34)
Asia (4242)
Australia (747)
California (1781)
Canada (356)
China (67)
Colorado (64)
Connecticut (95)
Delaware (64)
Europe (12257)
Florida (202)
Georgia (49)
Illinois (104)
Indiana (99)
Japan (39)
Maine (36)
Maryland (180)
Massachusetts (1223)
Michigan (49)
Minnesota (77)
New Jersey (373)
New York (376)
North Carolina (165)
Northern California (799)
Pennsylvania (313)
South America (117)
Southern California (688)
Texas (248)
Utah (60)
Virginia (46)
Washington State (198)
114,770 Results for "q straint".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales
The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, bringing in almost $700 million in the third quarter. Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3.
October 25, 2024
·
3 min read
·
Tristan Manalac
Press Releases
Medexus Announces Strong Fiscal Q2 2025 Results
Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA* of $6.0 million Management to host conference call at 8:00 AM Eastern time on Friday, November 8, 2024
November 7, 2024
·
23 min read
Podcast
Pfizer’s Q3 Earnings Win, Deals Galore, Countdown to Election, More
Pfizer, Sanofi and others report Q3 beats; AbbVie, Roche and Novartis strike big deals; the 2024 presidential election looms; and
BioSpace
takes a look back at 10 years of NextGen, our annual pick of young biotechs to watch.
October 30, 2024
·
1 min read
·
Heather McKenzie
Podcast
Q3 Earnings Kick Off With J&J, Bluebird in Tough Spot, Novo-Catalent Deal Under Fire, More
J&J beat expectations this week to launch the Q3 earnings season; a study about children treated with bluebird bio’s Skysona comes at a bad time for the company; Sen. Warren calls for scrutiny of Novo’s purchase of Catalent; and other news.
October 16, 2024
·
1 min read
·
Heather McKenzie
Deals
Biopharma VC Funding in Q2 Reaches Highest Quarterly Level Since 2022
Venture capital in the sector hit $9.2 billion in the second quarter of 2024, up from $7.4 billion in Q1, while exits fell on a slower M&A cycle and picky IPO market.
August 23, 2024
·
3 min read
·
Kate Goodwin
Press Releases
Microbix Schedules Release of Results for Q4 Fiscal 2024
December 13, 2024
·
3 min read
Press Releases
Medexus Announces Strong Fiscal Q1 2025 Results
Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA* of $6.1 million Management to host conference call at 8:00 AM Eastern time on Thursday, August 8, 2024
August 8, 2024
·
20 min read
Press Releases
Q32 Bio Joins Russell 3000® Index
Q32 Bio Inc. today announced that the company is joining the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell Indexes annual reconstitution, effective upon the U.S. market opening today, July 1, 2024.
July 1, 2024
·
6 min read
Business
Theralase(R) Release’s 1Q2024 Financial Statements
Theralase Technologies Inc. has released the Company’s unaudited interim consolidated 1Q2024 financial statements.
May 30, 2024
·
14 min read
Press Releases
bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
September 30, 2024
·
1 min read
1 of 11,477
Next
